When occupational therapists are determining an individual's fitness to drive, they do so primarily by conducting comprehensive driving evaluations, which typically consist of off-and onroad assessments. In many cases, drivers whose fitness to drive has been questioned are referred by Epilepsy, characterized by recurrent seizures resulting in altered neurological function (Tippin, Sparks, & Rizzo, 2009 ), can pose a risk to road safety Sheth, Krauss, Krumholz, & Li, 2004) due to impairments of motor, visual, and cognitive skills (Drazkowski, 2007) . One way to control seizures is through the use of antiepileptic drugs (AEDs). While AEDs result in seizure remission in approximately two-thirds of people with epilepsy (World Health Organization, 2005) , the side effects of some of these medications may impair multiple domains of cognition, such as memory and attention (Meador et al., 1995) , and may cause blurred vision and/or fatigue (Drazkowski, 2007) . For example, topiramate, a commonly used AED, causes confusion, dizziness, fatigue, and decreased concentration in patients with seizures (Shorvon, 1996) . Another AED, zonisamide, produces other cognitive deficits, such as impairment of communication skills and recall of visual-graphic task stimuli, and may cause sleepiness in patients with partial seizures (Berent et al., 1987) . Because cognitive and visual processing skills are important to driving, AEDs may also adversely impact driving performance.
In a double-blind randomized crossover study in 27 healthy drivers without neurological conditions, simulated driving performance was compared at baseline (no meds) and after dosages of either carbamazepine (CBZ) or oxcarbamazepine (OXC) were administered and progressively increased (Kaussner et al., 2010) . The participants made significantly more lane maintenance errors and more total driving errors when taking both AEDs. When comparing the two drugs, the participants taking CBZ made significantly more total driving errors than when taking OXC, indicating that CBZ may have more adverse side effects on driving (Kaussner et al., 2010) .
Comparatively, another study examined the effects of AED dosages on driving performance in healthy drivers without neurological conditions on a road test (Ramaekers et al., 2002) . The participants were randomized into three groups (600 mg of CBZ vs. Table 1 . Low-dose AED was determined if the patient was taking < 50% of the original AED doses at more than three half-lives for the specific AED prior to testing. "No medications" was designated if AED(s) had been discontinued for more than three half-lives prior to testing. The participants completed questionnaires on demographics, driving habits, and history, followed by driving on a high-fidelity DriveSafety DS-250r™ simulator, which is fully maneuverable on the EMU. 
Driving Simulator and Scenarios
The simulator design is based on a onefourth cab of an automatic transmission Ford Focus with a single adjustable seat and 5-point safety harness (see Figure 1) . To optimize driving close to the real world experience, the simulator was equipped with vehicle components (e.g., brake and gas pedal, air conditioning, turn signals). The simulator has a high-resolution display (1024 x 748 pixels) and provides the participants with a 110-inch horizontal view across three screens (each screen is 19 inches). The participants were required to adjust the seat and fasten the safety belt, and to control the steering wheel and gas and brake pedals. signaling, gap acceptance, and yielding (Shechtman et al., 2009) . As detailed in a prior study , the drive also included three scripted events that required the driver to avoid collisions:
one at a train crossing and two where a car enters the driving lane from a parked position. All of the participants had equal opportunities to make these errors over the two simulated drives.
Data Analysis
All data was entered into SPSS ( Statistical significance was considered for alpha ≤.
05 in a two-tailed test.
Results

Participants
Twenty-two participants enrolled in the study; however, only 11 were able to complete the entire protocol. Reasons for study incompletion included fatigue over the course of the hospital stay (e.g., being busy with family visitations) and the development of simulator sickness. The sample (six women; five men) ranged from 32 to 51 years of age (mean age of 42.1 ± 6.3), had an average high school education (12.6 years ± 3.0), and was all Caucasian. Eighty-two percent (n = 9) lived with their spouse or partner while two lived alone. After admission to the EMU, seven were diagnosed with epilepsy and four with conversion disorders (nonepileptic seizures). We did not segregate by epilepsy and convergent disorders as there were no differences in driving performance between the groups (z = -.878, p = .38) and the patients in both groups were taking AEDs.
Self-Reported Driving Habits and History
The participants reported driving 2.9 ± 3.4 days per week. Six of the 11 participants had quit driving prior to EMU admission. Two of the participants reported having been in a crash in the past three years, both current drivers. Four of the participants reported receiving citations in the past three years-three of which reported speeding infractions (two former and one current driver) and one an improper turning citation (current driver).
Twenty-seven percent (n = 3) of the sample reportedly avoided driving in the rain, during rush hour, on the highway, or at nighttime.
Simulated Driving Performance
Descriptive statistics for type and total number of driving errors during high and low AED dosages are provided in Table 2 . The most frequently committed driving errors in both low and high AED dosage drives included errors of speed regulation and lane maintenance. Generally, the participants made more total driving errors, as well as errors of visual scanning and speed regulations, while on their high compared to low AED dosage. 
Discussion
The findings suggest that occupational therapists need to consider the effects of AEDs when assessing fitness to drive in persons with seizures. Generally, the participants made more simulated driving errors while on their high compared to low AED dosages. Consistent with a prior study , the most commonly committed errors in the present study were speed regulation and lane maintenance errors.
Although individuals taking AED's may have more difficulties with speed regulation and lane maintenance, the findings suggest that driving may be affected for anyone taking AEDs for any reason, including pain, migraines, and mood disorders, consistent with prior findings (Kaussner et al., 2010; Ramaekers et al., 2002) . This has implications not only for persons with seizures but also for patients with other medical conditions who use AEDs.
We found that high AED dosages in our sample were significantly associated with errors of lane maintenance (driving wide) and gap acceptance. As AEDs impair aspects of cognition, namely attention (Drazkowski, 2007) , information processing speed (Wesnes, Edgar, Dean, & Wroe, 2009) , and concentration (Shorvon, 1996) , it is possible that our sample had more difficulty with proper lane maintenance and gap acceptance when taking high AED dosages. As seven of the 11 patients were actually unmedicated in the low dosage condition, it is also possible that there may have been a deterioration of simulator performance, which perhaps may have inflated the error measure in the low dosage condition overall. Different AED classes may have variable effects on the central nervous system, and given that the group was administered the same drug treatment, it is difficult to draw any conclusions regarding a specific AED on simulated driving performance. It is possible that certain AEDs may impair driving performance more so than others. For example, prior studies have found that on-road and simulated driving performance was worse when taking CBZ when compared to both OXC (Kaussner et al., 2010) and remacemide (Ramaekers et al., 2002) .
Limitations
The primary limitation of the present study was the small sample size (potential for type II error). However, our sample acted as their own controls, and we did ensure practice effects were not confounded by drug dosage. Although we recruited 22 participants for over two years, only 11 participants met the criteria of driving under both high and low AED dosages while at the EMU. Due to the loss of participants over the study protocol, our power to determine statistically meaningful inferences concerning the effects of different AED dosages on simulated driving performance was substantially reduced. Even though we obtained medication profiles from the participants' medical records, without monitoring AED serum levels (e.g., blood tests), we did not determine the actual AED dosage in their system at the time of the driving assessment. As a result, we could not determine if patients were in a steady state or whether some tolerance had developed, although we attempted to assess patients on the simulator immediately after AEDs were administered at the EMU. Additionally, future studies should also use AED serum levels to ascertain the effects of AED concentrations on driving performance.
Implications for Further Research
Understanding the effects of AEDs on driving performance will enhance decision-making when prescribing AEDs, as well as occupational therapy practice with respect to driver assessment.
